An in situ hydrogel-forming scaffold loaded by PLGA microspheres containing carbon nanotube as a suitable niche for neural differentiation

Many common neurological disorders, such as Parkinson's disease, stroke and multiple sclerosis, are caused by a loss of neurons and glial cells. In recent years, neurons and glia have been generated successfully from stem cells in culture, fueling efforts to develop stem-cell-based transplantation therapies for human patients. More recently, efforts have been extended to stimulating the formation and preventing the death of neurons and glial cells produced by endogenous stem cells within the adult central nervous system. The next step is to translate these exciting advances from the laboratory into clinically useful therapies.

This paper provides a review of the recent advances made in the field of electroactive polymers and composites for biomedical applications. Electrically conductive polymeric materials have recently attracted considerable interest from academic and industrial researchers to explore their potential in biomedical applications such as in biosensors, drug delivery systems, biomedical implants and tissue engineering. Conventional conductive homopolymers such as polypyrrole and PEDOT show promising conductivity for these applications, however their mechanical properties, biocompatibility and processability are often poor. This has led to more recent attention being directed towards conductive polymeric composites comprised of biostable/biocompatible polymers with dispersed conductive fillers such as graphene, carbon nanotubes and metallic nanoparticles. The major objective of this paper is to provide an up to date review of the recent investigations conducted in the development of conductive polymer composites focussing on the methods of their preparation, underlying concepts of their conductivity and the ways to tailor their properties. Furthermore, recent progress made in conventional conducting polymers and their composites/blends for biomedical applications is also discussed.

Stem cell-based approaches have received much hype as potential treatments for neurodegenerative disorders. Indeed, transplantation of stem cells or their derivatives in animal models of neurodegenerative diseases can improve function by replacing the lost neurons and glial cells and by mediating remyelination, trophic actions, and modulation of inflammation. Endogenous neural stem cells are also potential therapeutic targets because they produce neurons and glial cells in response to injury and could be affected by the degenerative process. As we discuss here, however, significant hurdles remain before these findings can be responsibly translated to novel therapies. In particular, we need to better understand the mechanisms of action of stem cells after transplantation and learn how to control stem cell proliferation, survival, migration, and differentiation in the pathological environment.